Investieren in die Zukunft von morgen.
Seite 120 von 229 Neuester Beitrag: 23.05.11 20:13 | ||||
Eröffnet am: | 25.06.09 04:47 | von: brunneta | Anzahl Beiträge: | 6.709 |
Neuester Beitrag: | 23.05.11 20:13 | von: buddikatze | Leser gesamt: | 477.243 |
Forum: | Hot-Stocks | Leser heute: | 89 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 118 | 119 | | 121 | 122 | ... 229 > |
man das wäre schön... :-)) urlaub für das ganze jahr .... :-))naja nur ein traum ...aber was nicht ist kann ja werden..
go cbai :-))
Written by Peter DePalma
Monday, 04 January 2010 04:48
http://biomedreports.com/articles/most-popular/...ti-bagger-cbai.html
1) The stock just emerged from sub-penny levels on incredible volume, but it appears that shares of CBAI are "priced" at a minimum of $.03 and could move to $.05 on this upcoming news event.
http://biomedreports.com/articles/most-popular/...ti-bagger-cbai.html
http://www.finanznachrichten.de/...s-a-south-american-company-008.htm
Cord Blood America Announces Cord Blood Stem Cell Processing and Storage Agreement With BioCells, a South American Company
LAS VEGAS, Jan. 4 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
"This is an excellent example of how our new laboratory and storage facility in Las Vegas allows us to significantly diversify our business model," said Matthew Schissler, co-founder and CEO. "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD). The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells' affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
"It is a revenue generator we have not had in the past. Not only do we have our own organic sales engine, our new lab can now generate gross profit by processing and storage agreements with other successful stem cell companies," Mr. Schissler commented. "BioCells has proven to be a tremendous company and we are fortunate to have entered into this letter of intent."
Cord Blood America recently announced a grand opening of its 17,000 square foot stem cell laboratory and headquarters in Las Vegas, near the city's international airport, on January 22, 2010.
The deal between Cord Blood America and BioCells is pending due diligence, and if it is completed successfully, anticipates the contract closing in the first quarter of 2010.
About Cord Blood America
Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
CONTACT: Paul Knopick E&E Communications 949/707-5365 pknopick@eandecommunications.com
http://www.biocells.com.ar/internacional_ing.html
gehören jetzt auch zu cbai....
http://translate.google.de/...mp;sl=en&tl=de&hl=&ie=UTF-8
http://www.prnewswire.com/news-releases/...ican-company-80587722.html
Dies zeigt erneut auf, dass die CBAI weiter intensiv an ihrer Expansion arbeitet und die Zusammenarbeit mit Partnern vorantreibt. Das Kurspotential bleibt nach wie vor hoch (meiner Meinung nach). Gehe eher nicht davon aus, dass der Kurs nochmals stark einbrechen wird. Bin auf die weitere Entwicklung gespannt.
http://translate.google.de/...mp;sl=en&tl=de&hl=&ie=UTF-8
ich wünsche euch allen noch einen schönen tag....mit cbai läuft es auch ganz gut und die meldungen gestern waren auch positiv...:-)) weiter so ...
lg bee :-))
Written by Staff and Wire Reports
Tuesday, 05 January 2010 05:49
http://biomedreports.com/articles/most-popular/...-ready-to-grow.html